Compare LEDS & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEDS | BNGO |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 11.6M |
| IPO Year | 2010 | 2018 |
| Metric | LEDS | BNGO |
|---|---|---|
| Price | $1.52 | $1.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 6.7K | ★ 98.5K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.12 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $43,009,000.00 | $12,000,735.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 729.81 | 26.26 |
| 52 Week Low | $1.41 | $1.06 |
| 52 Week High | $3.37 | $5.50 |
| Indicator | LEDS | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 37.04 | 39.95 |
| Support Level | N/A | $1.06 |
| Resistance Level | $1.63 | $1.18 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 4.72 | 44.55 |
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.